UNSPSC 51203400: Immunosupressant purines

This classification denotes heterocyclic pyrimidine-imidazole ring compounds present in many alkaloids and nucleic acids, substances called purines, that reduce a human host's humoral and/or cell-mediated defense mechanisms against deviant native cells, foreign organisms, or foreign substances (the human immune response and system thereof), thus the term IMMUNOSUPRESSANT PURINES.

UNSPSC 51203400 Immunosuppressant purines is a Class code, but the recent state and local opportunities tagged under it do not reflect immunosuppressant procurement. The Illinois Department of Public Health's awarded contract through the MMCAP Infuse consortium supplies antibiotics (Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg tablets), and Seminole County, Florida's solicitation targets naloxone and drug deactivation systems for community health and harm-reduction initiatives. Neither opportunity aligns with the code's nominal scope of immunosuppressant purine pharmaceuticals. The code shows little relevant recent activity under its stated classification.

State and local procurement agencies appear to be using this UNSPSC code inconsistently or as a catch-all category for pharmaceutical and medical supply procurement more broadly. The Illinois award, valued at $2,999,999.11 over a three-year term including renewals, was completed on August 28, 2026 through a piggyback vehicle (MMCAP Infuse consortium) and assigned to Chartwell Rx LLC following an Invitation for Bid process. Seminole County's IFB 60459723LAS, posted June 30, 2026 with response due July 26, 2026, sought 1,900 units of naloxone and 800 deactivation systems annually with quarterly deliveries to the County Community Health Building, including all shipping costs in vendor pricing. Both opportunities originate from state and local health departments and county-level health services providers, but neither represents immunosuppressant procurement activity. Business development professionals should verify UNSPSC tagging accuracy with issuing bodies before treating this code as an active market for immunosuppressant purines.